2 Stocks That Could Triple Your Investment by 2030
Projecting a company's future growth is a great way to figure out which businesses can meaningfully expand over the long run and increase wealth and which ones are simply over-hyped. While one of them could be a risky investment, both have credible paths to making shareholders a richer. Novo Nordisk (NYSE: NVO) is a Danish pharma company that's been in the news lately, thanks to its drug semaglutide.